Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoronaVac Phase III in Turkey
NCT04582344Phase 3Completed
- Sponsor
- TÜSEB
- Start
- Sep 2020
- Primary completion
- Jun 2022
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of coronavac in coronavirus disease 2019 (COVID-19), sponsored by TÜSEB. Started Sep 2020; status: completed.
02
Drugs
coronavac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04582344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04582344.